Nirsevimab immunization effectively decreases the risk for RSV-related LRTI hospitalizations in an infant's first year.
Ceftazidime-avibactam therapy yields a high clinical response rate in patients with MDR Gram-negative pneumonia in routine practice.
Long-term fumarate therapy for multiple sclerosis, compared with anti-CD20 therapy, is linked to a reduced risk for infection.
The HPV-FASTER protocol offers an approach to assess health system capacity for delivering integrated HPV vaccination and cervical screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results